Aslı Aksu Çerman

Aslı Aksu Çerman

Auto-generated profile, based on publicly available information

Aslı Aksu Çerman

University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Dermatology Department

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2014 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ACA. Aksu Cerman
A. Aksu Cerman
SSS. Sarikaya Solak
S. Sarikaya Solak
IAI. Kivanc Altunay
I. Kivanc Altunay

1 July 2016 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
AÇAslı Aksu Çerman
Aslı Aksu Çerman
EAEzgi Aktaş
Ezgi Aktaş
IAİlknur Kıvanç Altunay
İlknur Kıvanç Altunay
JAJanset Erkul Arıcı
Janset Erkul Arıcı
ATAysın Tulunay
Aysın Tulunay
FOFeyza Yener Ozturk
Feyza Yener Ozturk

1 March 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Demodex mites are found on the skin of many healthy individuals. Demodex mites in high densities are considered to play a pathogenic role. To investigate the association between Demodex infestation and the three most common facial dermatoses: acne vulgaris, rosacea and seborrheic dermatitis. This prospective, observational case-control study included 127 patients (43 with acne vulgaris, 43 with rosacea and 41 with seborrheic dermatitis) and 77 healthy controls. The presence of demodicosis was evaluated by standardized skin surface biopsy in both the patient and control groups. In terms of gender and age, no significant difference was found between the patients and controls (p>0.05). Demodex infestation rates were significantly higher in patients than in controls (p=0.001). Demodex infestation rates were significantly higher in the rosacea group than acne vulgaris and seborrheic dermatitis groups and controls (p=0.001; p=0.024; p=0.001, respectively). Demodex infestation was found to be significantly higher in the acne vulgaris and seborrheic dermatitis groups than in controls (p=0.001 and p=0.001, respectively). No difference was observed between the acne vulgaris and seborrheic dermatitis groups in terms of demodicosis (p=0.294). Small sample size is a limitation of the study. The lack of an objective scoring system in the diagnosis of Demodex infestation is another limitation. The findings of the present study emphasize that acne vulgaris, rosacea and seborrheic dermatitis are significantly associated with Demodex infestation. Standardized skin surface biopsy is a practical tool in the determination of Demodex infestation.

7 June 2020 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
IAIlknur Kivanc Altunay
Ilknur Kivanc Altunay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
SISena Inal
Sena Inal
EUEce Ugurer
Ece Ugurer
EÖEsen Özkaya
Esen Özkaya
Click on the article title to read more.

1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
DDDamla Demir
Damla Demir
IAIlknur Kıvanç Altunay
Ilknur Kıvanç Altunay
Currently, no generally accepted laboratory marker for monitorizing the disease activity and therapy response of psoriasis is known. The aim of the study is to evaluate the effects of systemic therapies on C-reactive protein (CRP) and the neutrophil-lymphocyte ratio (NLR) in psoriasis. One hundred patients with psoriasis treated with narrow band ultraviolet B, acitretin, cyclosporine, methotrexate, adalimumab, etanercept, and ustekinumab were prospectively evaluated. At baseline and at week 12, CRP, NLR, and Psoriasis Area and Severity Index (PASI) were evaluated. A statistically significant decrease was observed in PASI scores, CRP, and NLR values from the baseline to the 12-week visit (p=0.001, p=0.001, p=0.001, respectively). The reduction in PASI scores and NLR values was positively correlated (r=0.460, p=0.001). The comparisons between treatment groups revealed that the median decrease in NLR values was statistically higher in the adalimumab group than in the methotrexate group (p=0.007). And the median decrease in PASI scores was significantly higher in the adalimumab group compared with the methotrexate and acitretin therapy group (p=0.007, p=0.042, respectively). In the present study, systemic therapy of psoriasis was demonstrated to decrease the levels of CRP and NLR, which are known to be indicators of systemic inflammation and cardiovascular comorbidities.

1 January 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
DDDamla Demir
Damla Demir
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Psoriasis is a chronic immune-mediated inflammatory skin disease that is associated with cardiovascular comorbidities. The objective of this retrospective study is to assess the C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio as inflammatory markers in patients with psoriasis and to search for a relationship between these parameters and psoriasis severity, as defined by the psoriasis area and severity index. There were 94 patients with psoriasis and 118 healthy controls enrolled in the study. The C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio values of two groups were retrospectively evaluated. Statistically significant differences were observed in terms of C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio between the patient and control groups (p=0.001, p=0.003, p=0.038, and p=0.007, respectively). Positive correlations were found between the psoriasis area and severity index and the values of C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio (r: 0.381; p<0.01, r: 0.203; p<0.05, r: 0.268; p<0.01, r: 0.374; p<0.01, r: 0.294; p<0.01, respectively). The small sample size and the retrospective design of the study are limitations. Elevated C-reactive protein, monocyte-to-high-density-lipoprotein ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio were significantly associated with psoriasis. A positive correlation between C-reactive protein and monocyte-to-high-density-lipoprotein ratio leads to the suggestion that monocyte-to-high-density-lipoprotein ratio might be a reliable parameter in psoriasis during the follow-up. The relationship between the diasease and inflammatory parameters might provide early detection of cardiovascular morbidities in psoriasis patients.